A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clomipramine Impurity 9 - Request Quote

Picture of Clomipramine Impurity 9

Clomipramine Impurity 9

SZ CAT No:SZ-C012026
CAS No
NA
Mol.F.
C20H19NO3
Mol.Wt.
321.4
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Clomipramine Impurity 9 is chemically 1,1',1''-(10,11-Dihydro-5H-dibenzo[b,f]azepine-3,5,7-triyl)tris(ethan-1-one). Clomipramine Impurity 9 is supplied with detailed characterization data compliant with regulatory guideline. Clomipramine Impurity 9 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Clomipramine.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality Clomipramine Impurity 9

Purchase Clomipramine Impurity 9

Clomipramine Impurity 9 suppliers

Clomipramine Impurity 9 manufacturers

Clomipramine Impurity 9 price

Order Clomipramine Impurity 9

Enquire Clomipramine Impurity 9

Clomipramine Impurity 9 cost

Clomipramine Impurity 9 Supplier

Clomipramine Impurity 9 Distributor

Clomipramine Impurity 9 for Method Validation

Clomipramine Reference Standard

Clomipramine Impurity 9 for ANDA Filing

Clomipramine Impurity 9 for Forced Degradation Studies

Clomipramine Impurity 9 Identification Standards

Clomipramine Impurity 9 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,